A rising body temperature, the very feature the condition is named for, is one of the most well-recognized late signs of malignant hyperthermia. Other late signs include muscle breakdown severe enough to darken the urine, dangerous potassium spikes, abnormal heart rhythms, and widespread clotting problems. The fact that the fever arrives late in the crisis is clinically important, because waiting for it before acting can cost a patient their life. The earlier warning signs look nothing like a fever, and understanding the full timeline of this rare anesthetic emergency helps explain why.
Why the Name Misleads
Malignant hyperthermia (MH) sounds like a disease defined by high temperature, and in a sense it is: without treatment, core body temperature can climb past 40 °C and keep going. But the temperature spike is one of the last dominoes to fall, not the first. The earliest detectable change is a sudden, unexplained rise in end-tidal carbon dioxide, the COâ‚‚ measured in a patient’s exhaled breath during surgery. That carbon dioxide surge reflects a metabolic firestorm already raging in skeletal muscle well before the thermometer catches up.
Multiple clinical reviews stress this point explicitly. One widely cited review in the anesthesia literature describes hyperthermia as “often a late sign, with temperature rising precipitously,” and emphasizes that early diagnosis depends on recognizing unexplained hypercapnia and muscle rigidity instead.1JMSMA. Top Ten Facts You Need to Know About the Perioperative Management of Malignant Hyperthermia Another review of MH’s classic presentation lists tachycardia, tachypnea, increased COâ‚‚ production, acidosis, and muscle rigidity alongside the temperature rise, but singles out end-expired carbon dioxide elevation as the key early diagnostic clue.2PubMed Central. Malignant hyperthermia In practice, the anesthesiologist watching a COâ‚‚ monitor has a head start of minutes to tens of minutes over anyone waiting to feel warm skin.
The Early Warning Signs That Come First
If the fever is late, what comes early? The first thing an anesthesiologist usually notices is the capnograph climbing. The machine measuring exhaled COâ‚‚ shows numbers rising steadily even though the ventilator settings haven’t changed. This is the metabolic signal: muscles throughout the body are burning through energy at a runaway pace, producing carbon dioxide as a byproduct faster than the lungs can clear it.
Shortly after, or sometimes simultaneously, heart rate starts climbing. Sinus tachycardia in a patient who was hemodynamically stable minutes ago, with no obvious surgical explanation, is a red flag. Muscle rigidity may also appear early. A particularly classic presentation is masseter spasm, where the jaw muscles clamp down tightly right after succinylcholine is given, making it difficult or impossible to open the patient’s mouth for intubation. Masseter rigidity following succinylcholine is considered an early warning sign for a possible MH episode.3PubMed Central. Succinylcholine-Induced Masseter Muscle Rigidity Successfully Managed With Propofol and Laryngeal Mask Airway: A Case Report and Brief Review
These early signs, rising COâ‚‚, fast heart rate, and rigid muscles, all emerge before the body temperature begins to visibly climb. They are the window of opportunity. Catching MH at this stage dramatically improves outcomes. Missing them and waiting for the fever means the crisis is already well advanced.
The Full Spectrum of Late Signs
Once the hypermetabolic cascade has been running unchecked for a while, the late signs pile up. Each one represents a different organ system being overwhelmed by what is fundamentally a muscle problem that has spilled over into the rest of the body.
- Hyperthermia: Core temperature can rise at a rate of 1–2 °C every five minutes in severe cases. This is the namesake sign, and by the time it is obvious, metabolic derangement is already severe.
- Rhabdomyolysis: Sustained, uncontrolled muscle contraction physically destroys muscle fibers. The contents of those fibers, including myoglobin and potassium, spill into the bloodstream. One case report describes a patient who developed dark (“black”) urine after surgery from myoglobin flooding the kidneys, a hallmark of advanced rhabdomyolysis triggered by MH.4Journal of the American Society of Nephrology. Black Urine after Surgery: Rare Cause of Rhabdomyolysis and Malignant Hyperthermia Syndrome (MHS)
- Hyperkalemia: Potassium released from dying muscle cells raises blood potassium to dangerous levels, which can destabilize the heart’s electrical activity.
- Cardiac arrhythmias: Between the high potassium, the acidosis, and the extreme body temperature, the heart can develop irregular rhythms that may progress to cardiac arrest.
- Metabolic acidosis: Lactic acid builds up as muscles consume ATP faster than oxidative metabolism can supply it, driving blood pH down.
- Disseminated intravascular coagulation: In severe, prolonged episodes, the clotting system can go haywire, leading to both abnormal clotting throughout the vasculature and paradoxical bleeding as clotting factors are consumed.
These late signs are not independent events. They feed into each other. Rhabdomyolysis causes hyperkalemia, which worsens arrhythmias. Acidosis makes the heart more sensitive to potassium. Extreme heat damages proteins and membranes everywhere, accelerating organ failure. By the time a patient is showing multiple late signs simultaneously, the situation is a genuine emergency even with treatment underway.
What Is Happening Inside the Muscle
The underlying problem in MH is a genetic defect in a calcium-release channel in skeletal muscle. When certain anesthetic agents are used in a susceptible person, that channel essentially gets stuck open, flooding the inside of muscle cells with calcium. Calcium is the signal that tells a muscle fiber to contract, so a constant flood of it produces continuous, unrelenting contraction. That sustained contraction consumes enormous amounts of energy, generates heat and COâ‚‚, and eventually physically tears the muscle fibers apart.
The defective channel, called the ryanodine receptor (specifically the RyR1 isoform found in skeletal muscle), is the target of mutations that create MH susceptibility. Research has confirmed that mutations in RyR1 cause channel leakage, leading to an intracellular calcium increase that triggers the potentially lethal MH episode.5bioRxiv. Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM The triggering agents, volatile anesthetic gases and the muscle relaxant succinylcholine, interact with this already-leaky channel in susceptible individuals and push it past its tipping point.
Which Drugs Trigger It
Not all anesthetic agents are dangerous for MH-susceptible individuals. The triggers fall into two categories. Volatile (inhaled) anesthetics, including halothane, enflurane, isoflurane, desflurane, and sevoflurane, are the primary culprits. The other major trigger is succinylcholine, a depolarizing muscle relaxant commonly used to facilitate intubation.6Brieflands / Journal of Cellular & Molecular Anesthesia. A Case of Malignant Hyperthermia Induced by Volatile Anesthetics: Clinical Management and Treatment Either class can trigger an episode alone, or the two can act together.
Intravenous anesthetics like propofol, opioids, benzodiazepines, and non-depolarizing muscle relaxants are considered safe for MH-susceptible patients. So is nitrous oxide. This means that someone known to be susceptible can still undergo general anesthesia, but the anesthetic plan has to be carefully designed to avoid the triggering agents entirely. Regional anesthesia (spinal or epidural blocks) and local anesthetics are also safe alternatives.
The Genetics Behind Susceptibility
MH susceptibility is inherited in an autosomal dominant pattern, meaning a single copy of a causative mutation from one parent is enough to put someone at risk. However, the genetic picture is more complicated than a single gene with a single mutation. Most identified mutations sit in the RYR1 gene, but not everyone who tests positive on a muscle biopsy carries a detectable RYR1 variant. A study of MH-susceptible families in a Slavonic population found pathogenic or likely pathogenic RYR1 variants in 48% of families confirmed as susceptible by contracture testing. In another 18%, variants of uncertain significance were found. In 34% of confirmed MH-susceptible individuals, no variants were detected at all.7PubMed Central. Malignant Hyperthermia in Slavonic cohort – clinical and genetic findings beyond standard diagnostics
This means genetic testing alone cannot rule out MH susceptibility. A negative genetic test in a family with no prior MH history is reassuring but not definitive. When there is real clinical suspicion, the gold standard diagnostic tool remains the caffeine-halothane contracture test, in which a small piece of surgically biopsied muscle is exposed to caffeine and halothane in a lab to see whether it contracts abnormally. Research has documented that false-negative results with this test are rare, supporting its reliability as a diagnostic method for a potentially serious condition.8PubMed. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia The downside is that it requires an open muscle biopsy, typically from the thigh, and is only performed at specialized centers.
Treatment Once the Crisis Begins
The drug that stops an MH crisis is dantrolene sodium, which works by directly blocking the runaway calcium release from the ryanodine receptor. When given early, it can halt the metabolic cascade rapidly. Structural biology research has recently visualized exactly how dantrolene binds within a specific cavity of the RyR1 channel, nestling among key amino acid residues and physically preventing the channel from leaking calcium.9Structure. Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM
Beyond dantrolene, the management protocol involves stopping the triggering anesthetic immediately, hyperventilating the patient with 100% oxygen to blow off excess COâ‚‚, cooling the patient aggressively (ice packs, cold IV fluids, sometimes even body-cavity lavage), and treating the metabolic fallout: correcting acidosis, managing hyperkalemia, supporting the heart, and protecting the kidneys from myoglobin damage. Surgery is halted or finished as quickly as possible.
The question of whether dantrolene should be stocked at every facility that administers triggering agents is not trivial. An analysis estimated that roughly 47 MH events occur per year in U.S. ambulatory surgery centers, and stocking dantrolene compared to supportive care alone would save about 33 additional lives per year, at an incremental cost of about $196,000 per life saved.10PubMed. Cost-effectiveness analysis of stocking dantrolene in ambulatory surgery centers for the treatment of malignant hyperthermia For a condition this rare, maintaining readiness everywhere surgery happens is a logistical challenge, but the stakes when it does occur are extreme.
The Risk of Recurrence After Initial Treatment
Even after a successful initial treatment, MH can come back. Recrudescence, where the crisis reignites hours after it apparently resolved, is a recognized hazard. In one documented case, a 25-year-old man who had been promptly treated with dantrolene during tonsillectomy was stable and fever-free overnight in the ICU. Eighteen hours later, shortly after his breathing tube was removed, an episode of shivering was followed by tachycardia, high blood pressure, rapid breathing, and a rapid temperature spike. He was treated with another dose of dantrolene and recovered, but the case illustrated that post-extubation shivering may have been either a trigger or an early indicator of recurrence.11British Journal of Anaesthesia. Suspected recurrence of malignant hyperthermia after post-extubation shivering in the intensive care unit, 18 h after tonsillectomy
Because of this recurrence risk, patients who experience an MH episode are typically monitored in an intensive care setting for at least 24 hours afterward, with dantrolene kept immediately available. The metabolic instability that drives MH does not necessarily switch off the moment the triggering agent is removed, particularly if muscle damage is extensive and intracellular calcium stores are still dysregulated.
Long-Term Effects After Surviving an Episode
Surviving an MH crisis does not necessarily mean walking away unscathed. A survey of MH survivors found persistent musculoskeletal problems in a substantial proportion. Among 23 respondents, muscle cramps were reported by 12, muscle pain by 10, back or joint pain by 11, and muscle weakness by 8. Most of these symptoms worsened over time, and the vast majority of survivors attributed their ongoing muscle pain and weakness directly to their MH event.12Open Journal of Anesthesiology. Survey of Long-Term Sequelae in Survivors of a Malignant Hyperthermia Reaction Muscle weakness, for example, increased after the event and persisted at a comparable level over time, with every affected respondent attributing it to MH.
These long-term effects make sense when you consider the mechanism. Rhabdomyolysis during an MH episode can destroy a meaningful amount of muscle tissue. Depending on the severity and duration of the crisis before treatment, the resulting muscle loss and scarring may never fully resolve. Kidney damage from myoglobin is another potential lasting consequence in severe cases, though aggressive hydration during the acute phase helps protect against it.
MH Susceptibility in Pigs and What It Taught Us
Much of what we know about MH came from studying pigs. Certain pig breeds, particularly heavily muscled ones bred for lean meat production, carry a high prevalence of MH susceptibility. The condition in pigs is known as porcine stress syndrome, and affected animals can develop a full MH-like crisis not just from anesthetics but from physical stress, heat, and even the stress of transport to slaughter. Research using halothane-susceptible pigs explored whether drugs like acepromazine and droperidol could inhibit the development of MH episodes triggered by halothane.13American Journal of Veterinary Research. Acepromazine and Droperidol Inhibition of Halothane-Induced Malignant Hyperthermia (Porcine Stress Syndrome) in Swine
The pig model was instrumental in working out the calcium-release mechanism, in testing dantrolene as a treatment, and in developing the contracture testing protocols that remain the diagnostic standard today. The parallel between human MH and porcine stress syndrome also raised practical questions for the meat industry: pale, soft, exudative pork, a major quality defect, turned out to be the carcass-level consequence of the same genetic susceptibility. The genetics-to-phenotype story in pigs was actually worked out faster than in humans, partly because pig breeding programs made it easier to track inheritance patterns through large pedigrees.